Aaron M. Gruver

发表

Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classification.

R. Tubbs, B. Portier, Aaron M Gruver, 2011, Archives of pathology & laboratory medicine.

Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders.

Xiao-Jun Ma, Yuling Luo, R. Tubbs, 2013, American journal of clinical pathology.

Functional characterization and identification of mouse Rad51d splice variants

C. McInnes, B. Yard, D. Pittman, 2009, BMC Molecular Biology.

From morphologic to molecular: established and emerging molecular diagnostics for breast carcinoma.

R. Tubbs, B. Portier, Eugen C. Minca, 2012, New biotechnology.

The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C.

J. Albala, D. Pittman, S. Kaliyaperumal, 2005, Mutagenesis.

Extensive chromosomal instability in Rad51d-deficient mouse cells.

D. Pittman, Phillip G. Smiraldo, Aaron M Gruver, 2005, Cancer research.

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-line Treatment for EGFR-mutation Positive NSCLC Patients.

C. Schumann, N. Girard, G. Scagliotti, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.

J. McKenney, M. Amin, A. Osunkoya, 2012, Archives of pathology & laboratory medicine.

Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)

T. Holzer, K. Credille, J. Lu, 2014, Histopathology.

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response

C. Escriu, J. Field, M. Davies, 2019, Lung cancer.

Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry

R. Slebos, D. Liebler, J. Gosney, 2020, Laboratory Investigation.

Fibrin-associated Large B-cell Lymphoma: Part of the Spectrum of Cardiac Lymphomas

Ahmet Dogan, A. Dogan, E. Hsi, 2012, The American journal of surgical pathology.

Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma

R. Tubbs, Z. Peerwani, Aaron M. Gruver, 2010, Journal of Clinical Pathology.

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma

R. Tubbs, G. Budd, E. Downs-Kelly, 2013, Oncotarget.

Novel ophthalmic pathology in an autopsy case of autosomal dominant retinal vasculopathy with cerebral leukodystrophy.

L. Schoenfield, R. Hajj-Ali, J. Coleman, 2011, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Automated quantitative RNA in situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinoma.

Xiao-Jun Ma, Raymond R Tubbs, Yuling Luo, 2013, The Journal of molecular diagnostics : JMD.

A novel immunohistochemical scoring system reveals associations of C-terminal MET, ectodomain shedding and loss of E-cadherin with poor prognosis in oral squamous cell carcinoma.

D. Nieboer, L. Looijenga, R. J. Baatenburg de Jong, 2020, Human pathology.

MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma

D. Nieboer, L. Looijenga, S. Willems, 2019, Modern Pathology.

Targeted Quantitative Mass Spectrometry Analysis of Protein Biomarkers From Previously Stained Single Formalin-Fixed Paraffin-Embedded Tissue Sections.

M. Westfall, B. Butts, S. Hill, 2023, Laboratory investigation; a journal of technical methods and pathology.

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer

D. Rimm, J. Zugazagoitia, Kyla E. Driscoll, 2021, Cancers.

Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer

K. Syrigos, D. Rimm, J. Zugazagoitia, 2021, Cancers.

Two Instrument Comparison of Reagents From a US FDA-Approved Assay for the Assessment of Ki-67 in High-Risk Early Breast Cancer

S. Wijayawardana, E. Downs-Kelly, Aaron M Gruver, 2022, Applied immunohistochemistry & molecular morphology : AIMM.

A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone

M. Press, M. Method, D. Hanks, 2022, Applied immunohistochemistry & molecular morphology : AIMM.

Analysis of Peripheral T‐cell Lymphoma Diagnostic Workup in the United States

R. Advani, Sonali M. Smith, A. Tulpule, 2017, Clinical lymphoma, myeloma & leukemia.

MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis

Su-Jin Shin, H. Chung, V. Wacheck, 2018, Journal of surgical oncology.

The interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysis

V. Basrur, D. Pittman, C. Rajesh, 2009, Proteomics.

Cellular Analyses of the RAD51-related Homologous Recombination Repair Proteins

Aaron M. Gruver, 2005 .

Modified Array-based Comparative Genomic Hybridization Detects Cryptic and Variant PML-RARA Rearrangements in Acute Promyelocytic Leukemia Lacking Classic Translocations

B. Ballif, R. Tubbs, R. Schultz, 2013, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity

D. Liebler, M. Westfall, D. Gemperline, 2021, Journal of Clinical Pathology.

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer

T. Holzer, D. Liebler, B. Ackermann, 2020, Scientific Reports.

P1.04-24 Digital Core Needle-Biopsy to Assess PD-L1 Expression in Non-Small Cell Lung Cancer: Optimal Sampling and Need for Re-Biopsy

C. Escriu, J. Field, M. Davies, 2018, Journal of Thoracic Oncology.

Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory.

A. Schade, Aaron M. Gruver, 2015, Archives of pathology & laboratory medicine.

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer

F. Baehner, C. Russell, S. Wijayawardana, 2022, Breast Cancer Research.